ResearcherSeoul National UniversityNo recent work listed
Sung Whan Ha
Matched on ORCID iD 0000-0001-8066-7232; OpenAlex author ID A5103271901. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 6
- Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancre… Last author DOI 10.4143/crt.2020.928↗
- Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. Last author DOI 10.21873/anticanres.11125↗
- Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study. Co-author DOI 10.4143/crt.2015.226↗
- Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer-Population-Based Analysis with Propensity Score Matching. Last author DOI 10.1007/s11605-015-2941-x↗
- Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma. Last author DOI 10.4143/crt.2014.025↗
- Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for… Co-author DOI 10.1007/s00280-012-1918-7↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eui Kyu Chie · 6 shared papers, 2012–2021 · strength 0.37
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer-Population-Based Analysis with Propensity Score Matching. DOI 10.1007/s11605-015-2941-x↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Seock‐Ah Im · 5 shared papers, 2012–2021 · strength 0.31
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Yung‐Jue Bang · 5 shared papers, 2012–2021 · strength 0.31
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Do‐Youn Oh · 4 shared papers, 2015–2021 · strength 0.28
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Kyubo Kim · 4 shared papers, 2015–2016 · strength 0.22
- Paper Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer-Population-Based Analysis with Propensity Score Matching. DOI 10.1007/s11605-015-2941-x↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Jin‐Young Jang · 3 shared papers, 2015–2021 · strength 0.22
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Paper Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatecto… DOI 10.4143/crt.2014.025↗
- Sun‐Whe Kim · 3 shared papers, 2015–2021 · strength 0.22
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy. DOI 10.21873/anticanres.11125↗
- Paper Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatecto… DOI 10.4143/crt.2014.025↗
- Kyung-Hun Lee · 2 shared papers, 2016–2021 · strength 0.17
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Kim Js · 2 shared papers, 2012–2021 · strength 0.15
- Paper Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemc… DOI 10.4143/crt.2020.928↗
- Paper Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent… DOI 10.1007/s00280-012-1918-7↗
- Yu Jin Lim · 1 shared paper, 2015 · strength 0.06
- Hyeon Kang Koh · 1 shared paper, 2016 · strength 0.06
- Younak Choi · 1 shared paper, 2016 · strength 0.05
- Ijin Joo · 1 shared paper, 2015 · strength 0.05
- Byoung Hyuck Kim · 1 shared paper, 2015 · strength 0.05
- Jin‐Hyeok Hwang · 1 shared paper, 2012 · strength 0.03
- Yong Bum Yoon · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.